These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24606459)

  • 1. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
    Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
    Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells.
    Qian Y; Deng J; Geng L; Xie H; Jiang G; Zhou L; Wang Y; Yin S; Feng X; Liu J; Ye Z; Zheng S
    Cancer Invest; 2008 Oct; 26(8):816-21. PubMed ID: 18608206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling.
    Qian Y; Deng J; Xie H; Geng L; Zhou L; Wang Y; Yin S; Feng X; Zheng S
    J Cancer Res Clin Oncol; 2009 Mar; 135(3):379-86. PubMed ID: 18825409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
    Berthon C; Driss V; Liu J; Kuranda K; Leleu X; Jouy N; Hetuin D; Quesnel B
    Cancer Immunol Immunother; 2010 Dec; 59(12):1839-49. PubMed ID: 20814675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
    Barsoum IB; Smallwood CA; Siemens DR; Graham CH
    Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling.
    Xiong HY; Ma TT; Wu BT; Lin Y; Tu ZG
    Asian Pac J Cancer Prev; 2014; 15(14):5767-72. PubMed ID: 25081699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance.
    Wang Y; Zhuang Q; Zhou S; Hu Z; Lan R
    J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):77-9. PubMed ID: 19224168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
    Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
    Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.
    Zhou TC; Sankin AI; Porcelli SA; Perlin DS; Schoenberg MP; Zang X
    Urol Oncol; 2017 Jan; 35(1):14-20. PubMed ID: 27816403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.
    Nakanishi J; Wada Y; Matsumoto K; Azuma M; Kikuchi K; Ueda S
    Cancer Immunol Immunother; 2007 Aug; 56(8):1173-82. PubMed ID: 17186290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.
    Gil-Julio H; Perea F; Rodriguez-Nicolas A; Cozar JM; González-Ramirez AR; Concha A; Garrido F; Aptsiauri N; Ruiz-Cabello F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.
    Liu J; Hamrouni A; Wolowiec D; Coiteux V; Kuliczkowski K; Hetuin D; Saudemont A; Quesnel B
    Blood; 2007 Jul; 110(1):296-304. PubMed ID: 17363736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.
    Kawahara T; Ishiguro Y; Ohtake S; Kato I; Ito Y; Ito H; Makiyama K; Kondo K; Miyoshi Y; Yumura Y; Hayashi N; Hasumi H; Osaka K; Muraoka K; Izumi K; Teranishi JI; Uemura H; Yao M; Nakaigawa N
    BMC Urol; 2018 Nov; 18(1):97. PubMed ID: 30400941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
    Xylinas E; Robinson BD; Kluth LA; Volkmer BG; Hautmann R; Küfer R; Zerbib M; Kwon E; Thompson RH; Boorjian SA; Shariat SF
    Eur J Surg Oncol; 2014 Jan; 40(1):121-7. PubMed ID: 24140000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
    Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
    Boorjian SA; Sheinin Y; Crispen PL; Farmer SA; Lohse CM; Kuntz SM; Leibovich BC; Kwon ED; Frank I
    Clin Cancer Res; 2008 Aug; 14(15):4800-8. PubMed ID: 18676751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
    Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-3-glucuronide upregulates PD-L1 expression
    Wang K; Wang J; Liu T; Yu W; Dong N; Zhang C; Xia W; Wei F; Yang L; Ren X
    Cancer Biol Med; 2021 Feb; 18(1):155-171. PubMed ID: 33628591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP4-AS1 promotes CD8
    Shen GY; Zhang Y; Huang RZ; Huang ZY; Yang LY; Chen DZ; Yang SB
    Immunol Res; 2024 Aug; 72(4):766-775. PubMed ID: 38687433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.